Representative before the EPO

Technology company logo thumb
no operation time available
3 offices
Technology Company

We have observed 25 EP applications Olivia Aline Furstoss has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after November 20, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP14150998

Adsorption of immunopotentiators to insoluble metal salts

IPC classification:
A61K 39/095, A61K 39/00, C07D 487/04, C07D 471/04, C07D 239/48
Applicant:
GlaxoSmithKline Biologicals SA
Applicant:
Novartis AG
Agent:
Olivia Aline Furstoss, GlaxoSmithKline
Agent:
Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP12718460

ADJUVANT NANOEMULSIONS WITH PHOSPHOLIPIDS

IPC classification:
A61K 39/39
Applicant:
GlaxoSmithKline Biologicals SA
Applicant:
Novartis AG
Agent:
Multiple attorneys, GlaxoSmithKline
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
GRANT OF PATENT INTENDED
EP13708142

IMMUNOLOGICALLY USEFUL ARGININE SALTS

IPC classification:
A61K 31/4375, C07D 471/04, A61P 37/04
Applicant:
GlaxoSmithKline Biologicals SA
Applicant:
Novartis AG
Agent:
Multiple attorneys, GlaxoSmithKline
Agent:
Carpmaels & Ransford LLP
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
PATENT GRANTED
EP14758351

LARGE SCALE PRODUCTION OF VIRUSES IN CELL CULTURE

IPC classification:
A61K 39/145, C12N 7/00
Applicant:
The Chemo-Sero-Therapeutic Research Institute (KAKETSUKEN)
Agent:
Olivia Aline Furstoss, GlaxoSmithKline
Status:
GRANT OF PATENT INTENDED
EP12704573

ADJUVANT NANOEMULSIONS WITH CRYSTALLISATION INHIBITORS

IPC classification:
A61K 31/4375, A61K 47/44, A61K 47/32, A61K 47/26, A61K 9/107
Applicant:
GlaxoSmithKline Biologicals SA
Applicant:
Novartis AG
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Agent:
Multiple attorneys, GlaxoSmithKline
Agent:
Carpmaels & Ransford LLP
Status:
PATENT GRANTED
EP14795571

CALCIUM FLUORIDE COMPOSITIONS

IPC classification:
A61K 39/39
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Olivia Aline Furstoss, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP14789550

CALCIUM FLUORIDE COMPOSITIONS

IPC classification:
A61K 39/39
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Olivia Aline Furstoss, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP16164271

COMPOSITIONS FOR INDUCING IMMUNE RESPONSES

IPC classification:
A61P 31/04, A61K 39/39, A61K 39/385, A61K 9/16
Applicant:
GlaxoSmithKline Biologicals SA
Applicant:
Novartis AG
Agent:
Olivia Aline Furstoss, GlaxoSmithKline
Agent:
Carpmaels & Ransford LLP
Status:
The patent has been granted
EP15716137

IMMUNOGENIC LIPOSOMAL FORMULATION

IPC classification:
A61K 31/00, A61K 9/127
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Olivia Aline Furstoss, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP15715431

LIPOSOMAL COMPOSITIONS FOR MUCOSAL DELIVERY

IPC classification:
A61K 9/127
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Olivia Aline Furstoss, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP15709964

OIL/SURFACTANT MIXTURES FOR SELF-EMULSIFICATION

IPC classification:
A61K 9/107, A61K 39/39
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Olivia Aline Furstoss, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP16190246

LIPIDATED OXOADENINE DERIVATIVES

IPC classification:
C07F 9/6561, A61P 37/04, A61K 31/522, A61K 31/52
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Olivia Aline Furstoss, GlaxoSmithKline
Status:
Request for examination was made
EP15791768

MAMMALIAN CELLS EXPRESSING CYTOMEGALOVIRUS ANTIGENS

IPC classification:
C12N 5/071, A61K 39/245, C07K 14/005
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Olivia Aline Furstoss, GlaxoSmithKline
Status:
Request for examination was made
EP15797460

ADENINE DERIVATIVES WHICH ARE USEFUL IN THE TREATMENT OF ALLERGIC DISEASES OR OTHER INFLAMMATORY CONDITIONS

IPC classification:
A61P 37/08, A61P 35/00, A61P 31/00, A61K 31/522, C07D 473/18
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Olivia Aline Furstoss, GlaxoSmithKline
Status:
Request for examination was made
EP15816413

A METHOD FOR A LARGE SCALE VIRUS PURIFICATION

IPC classification:
C12N 7/00
Applicant:
GlaxoSmithKline Biologicals SA
Applicant:
The Chemo-Sero-Therapeutic Research Institute (KAKETSUKEN)
Agent:
Olivia Aline Furstoss, GlaxoSmithKline
Status:
Request for examination was made
EP16702211

CMV ANTIGENS AND USES THEREOF

IPC classification:
A61K 39/00, C07K 16/08, C07K 14/005, A61K 39/245
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Olivia Aline Furstoss, GlaxoSmithKline
Status:
Request for examination was made
EP16702210

CYTOMEGALOVIRUS ANTIGENS AND USES THEREOF

IPC classification:
C07K 14/005, A61K 39/245, C07K 16/08
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Olivia Aline Furstoss, GlaxoSmithKline
Status:
Request for examination was made
EP16707035

OIL/SURFACTANT MIXTURES FOR SELF-EMULSIFICATION

IPC classification:
A61K 9/107, A61K 47/26, A61K 47/06, A61K 9/00
Applicant:
Northeastern University
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Olivia Aline Furstoss, GlaxoSmithKline
Status:
Request for examination was made
EP16710820

COMPOSITIONS AND USES

IPC classification:
A61K 39/00, A61K 31/522, A61K 39/39
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Olivia Aline Furstoss, GlaxoSmithKline
Status:
Request for examination was made
EP16808612

NOVEL ADJUVANT FORMULATIONS

IPC classification:
A61K 39/39
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Olivia Aline Furstoss, GlaxoSmithKline
Status:
Request for examination was made
EP16819296

PHOSPHOLIPIDATION OF IMIDAZOQUINOLINES AND OXOADENINES

IPC classification:
C07F 9/6558
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Olivia Aline Furstoss, GlaxoSmithKline
Status:
Request for examination was made
EP16819499

USE OF ADJUVANTS FOR THE PREVENTION AND/OR TREATMENT OF AUTOIMMUNE DISEASES

IPC classification:
A61K 47/22, A61K 39/39
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Olivia Aline Furstoss, GlaxoSmithKline
Status:
Request for examination was made
EP16809811

VACCINE

IPC classification:
A61P 31/00, A61K 39/39
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Olivia Aline Furstoss, GlaxoSmithKline
Status:
Request for examination was made
EP16829072

DRIED COMPOSITION

IPC classification:
A61K 39/12, A61K 39/015, A61K 39/00
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Olivia Aline Furstoss, GlaxoSmithKline
Status:
Request for examination was made
EP16809802

PEGYLATED IMIDAZOQUINOLINES AS TLR7 AND TLR8 AGONISTS

IPC classification:
A61K 39/39, A61P 17/12, A61P 31/20, A61P 35/00, A61P 31/14, A61K 31/4745, C07F 9/6561
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Olivia Aline Furstoss, GlaxoSmithKline
Status:
Request for examination was made

Please Sign in to use this feature